Home
Name
PHRT
Alternate names
None
Primary Site
None
Histology
None
Radiation
None
Remarks
None
Drugs for PHRT
Name
Alternate Names
Ibenzmethyzin Hydrochloride
Matulane
Methylhydrazine
N-Methylhydrazine
Natulan
Natulane
Procarbazine hydrochloride
Ro-4-6467
Ro4-6467/1
Abbreviations
IBZ
MIH
PCB
PCH
PCI
PCZ
Category
Chemotherapy
Subcategory
Nonclassic alkylating agent
NSC Number
077213
77213
Primary Site
Histology
None
Remarks
An orally administered hydrazine derivative antineoplastic agent. FDA approved in stages III, IV Hodgkin's lymphoma.
Coding
This drug should be coded
Name
Alternate Names
Ancef
Apo-Cefaclor
Apo-Cephalex
Ceclor
Ceclor CD
Cedax
Cefaclor
Cefadroxil
Cefadyl
Cefamandole
Cefazolin
Cefdinir
Cefditoren
Cefepime
Cefixime
Cefizox
Cefobid
Cefonicid
Cefoperazone
Cefotan
Cefotaxime
Cefotetan
Cefoxitin
Cefpodoxime
Cefprozil
Ceftazidime
Ceftibuten
Ceftin
Ceftizoxime
Ceftriaxone
Cefuroxime
Cefzil
Cephalexin
Cephalothin
Cephapirin
Cephradine
Ceporacin
Ceptaz
Claforan
Duricef
Fortaz
Keflex
Keflin
Keftab
Kefurox
Kefzol
Mandol
Maxipime
Mefoxin
Monocid
Novo-Lexin
Nu-Cephalex
Omnicef
PMS-Cephalexin
Rocephin
Suprax
Tazicef
Tazidime
Vantin
Velosef
Zinacef
Abbreviations
None
Category
Ancillary Agent
Subcategory
Antibacterial
NSC Number
None
Primary Site
None
Histology
None
Remarks
None
Coding
This drug should NOT be coded
Name
Alternate Names
Carbamo-hydroximic acid
Carbamohydroxamic acid
Carbamoyl oxime
Droxia
Hidrix
Hydrea
Hydreia
hydroxy-
Hydroxycarbamide
Hydroxycarbamine
Hydroxyl-urea
Hydura
Litaler
Litalir
Onco-Carbide
Oxyurea
SQ-1089
Urea
WR-83799
Abbreviations
HU
HUR
HYD
Category
Chemotherapy
Subcategory
Miscellaneous agent
NSC Number
032065
32065
Primary Site
Histology
None
Remarks
FDA approved uses on chronic myelogenous leukemia, head and neck cancers, melanoma, and advanced ovarian cancer.
Coding
This drug should be coded
